Advil, marketed by SKB, along with Bristol Myers's Nuprin, promptly came to market, benefiting from ibuprofen's successful ten-year track record.
Advil, launched by SKB in conjunction with Bristol Myers's Nuprin, hit the shelves promptly, capitalizing on ibuprofen's successful ten-year history.